Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Treatment interruption and variation in tablet taking behaviour result in viral failure: a case-control study from Cape Town, South Africa.
Ncaca, L-N; KRANZER, K; Orrell, C;
2011
PloS one, (2011).6 8 10.1371/journal.pone.0023088.
Integrated tuberculosis and HIV care in a resource-limited setting: experience from the Martin Preuss centre, Malawi.
Phiri, S; KHAN, PY; GRANT, AD; Gareta, D; Tweya, H; Kalulu, M; Chaweza, T; Mbetewa, L; Kanyerere, H; Weigel, R; Feldacker, C;
2011
Tropical medicine & international health, (2011).16 11 10.1111/j.1365-3156.2011.02848.x.
Quality of induced sputum using a human-powered nebuliser in a mobile human immunodeficiency virus testing service in South Africa.
KRANZER, K; Olson, L; Van Schaik, N; Raditlhalo, E; Hudson, E; Panigrahi, P; Bekker, L-G;
2011
The international journal of tuberculosis and lung disease, (2011).15 8 10.5588/ijtld.10.0684.
Incorporating household structure into a discrete-event simulation model of tuberculosis and HIV.
Mellor, GR; Currie, CS M; CORBETT, EL;
2011
ACM transactions on modeling and computer simulation, (2011).21 4 10.1145/2000494.2000499.
LIFETIME FOLLOW-UP OF MYCOBACTERIUM TUBERCULOSIS INFECTED INDIVIDUALS INCLUDING THOSE WITH SUBSEQUENT HIV INFECTION.
CRAMPIN, A; Longwe, H; Mulawa, D; Mwaungulu, L; GLYNN, J; DOCKRELL, H; FRENCH, N; FINE, P;
2011
Journal of epidemiology and community health, (2011).65, 10.1136/jech.2011.142976l.13.
Reducing tuberculosis-associated mortality among people with HIV.
GRANT, AD; Charalambous, S; Hoffmann, CJ; FIELDING, KL;
2011
AIDS (London, England), (2011).25 12 10.1097/qad.0b013e328348fba1.
Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa.
TOGUN, T; Peterson, I; Jaffar, S; Oko, F; OKOMO, U; Peterson, K; Jaye, A;
2011
AIDS research and therapy, (2011).8 1 10.1186/1742-6405-8-24.
Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
Lawn, SD; Brooks, SV; KRANZER, K; Nicol, MP; Whitelaw, A; Vogt, M; Bekker, L-G; Wood, R;
2011
PLoS medicine, (2011).8 7 10.1371/journal.pmed.1001067.
Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms.
Rangaka, MX; Gideon, HP; Wilkinson, KA; Pai, M; Mwansa-Kambafwile, J; Maartens, G; GLYNN, JR; Boulle, A; FIELDING, K; Goliath, R; Titus, R; Mathee, S; Wilkinson, RJ;
2011
The European respiratory journal, (2011).39 1 10.1183/09031936.00058911.
The burden of TB-HIV in the EU: how much do we know? A survey of surveillance practices and results.
Kruijshaar, ME; Pimpin, L; ABUBAKAR, I; RICE, B; Delpech, V; Drumright, LN; Hollo, V; Huitric, E; Van de Laar, M; Amato-Gauci, A; Manissero, D; Ködmön, C;
2011
The European respiratory journal, (2011).38 6 10.1183/09031936.00198310.